Senior insider sale
President & CEO at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$1.60M
47.85K shares
What this filing means
KAKKIS EMIL D plans to sell 47.85K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $1.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/19/2023ACC: 0001971857-23-000764
DirectorOfficer· President & CEO
Since Mar 2026
47.85K
Shares to sell
$1.60M
Approx. market value
47.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
OPTIONS EXERCISE
CASH
10/19/2023
47.85KTotal acquired47.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/19/2023 | OPTIONS EXERCISE CASH | 47.85K | — |
| Total | 47.85K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
47.85K
Market value
$1.60M
10/19/2023
Total
Units
47.85K
Value
$1.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/19/2023 | 47.85K | $1.60M | NASDAQ | Planned |
| Total | 47.85K | $1.60M | ||